Investieren in die Zukunft von morgen.

http://seekingalpha.com/article/...s-to-invest-in-cord-blood-industry  

http://www.cordbloodstocks.com/  

grünt alles vor sich hin dax dow alles
vielleicht auch unser schätzken cbai :-)  

http://www.news-medical.net/news/20091023/...facility-on-MoneyTV.aspx  

.....auch wenn einer wieder meckert ;-)

0,0078$ oder höher

 

Was haltet ihr heute von den Umsätzen. Die News scheinen keinen so richtig
zu interessieren.  Was soll also groß passieren?  

und bitte nicht gleich wieder schimpfen!!! ;-)  

werden die umsatze gemacht :-)  

die Umsätze werden erst mit den Ami´s realisiert. Außerdem kann ich keinen verübeln das er seine guten CBAI Aktie in Übersee ordert. Also erst mal bis 15.30 Uhr warten und schauen was der Tag so bringt.

  

 

ansonsten sofort 20 % Verlust  

23.10.2009 14:03
Cord Blood America Details 2010 Business Strategies in Internet Interview
LAS VEGAS, Oct. 23 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com/) focused on bringing the life saving potential of stem cells, a biological insurance policy for families nationwide and internationally, today addressed current shareholder questions in an interview of Matthew Schissler, founder and CEO.

Click here to view the interview.

\"Our 2010 business strategy involves a shift in focus to acquiring more assets, organic growth and diversification and increase of our revenue streams,\" Mr. Schissler explains in the interview. Also included in the comprehensive interview is an update on the Company\'s new headquarters and laboratory in Las Vegas, an explanation on why the new laboratory is so important for investors, a discussion of the Company\'s debt reduction program, and a synopsis of successes in 2009.

Cord Blood America (BULLETIN BOARD: CBAI) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (BULLETIN BOARD: CBAI) , visit our website at http://www.corcell.com/. For investor information, visit http://www.cordblood-america.com/.

Forward-Looking Statements

Some statements made in this press release are forward-looking statements, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. We use words such as \"anticipate,\' \"believe,\' \"expect,\' \"future,\' \"intend,\' \"plan,\' and similar expressions to identify forward-looking statements. These statements including those related to the growth of the industry, new stem cell treatments, and the Company\'s performance, are only predictions and are subject to certain risks, uncertainties and assumptions. Additional risks are identified and described in the Company\'s public filings with the Securities and Exchange Commission. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. The Company\'s past performance is not necessarily indicative of its future performance. The Company does not undertake, and the Company specifically disclaims any obligation to update any forward-looking statements to reflect occurrences, developments, events, or circumstances after the date of such statement.

CONTACT:
Paul Knopick
E&E Communications
949/707-5365
pknopick@eandecommunications.com
Cord Blood America, Inc.

CONTACT: Paul Knopick, E&E Communications, +1-949-707-5365,
pknopick@eandecommunications.com

Web Site: http://www.cordblood-america.com/



© 2009 PR Newswire  

wenn plus dann richtig ich schätze 0,0085 usd

keine empfehlung  

LAS VEGAS, Oct. 23 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com/) focused on bringing the life saving potential of stem cells, a biological insurance policy for families nationwide and internationally, today addressed current shareholder questions in an interview of Matthew Schissler, founder and CEO.

Click here to view the interview.

"Our 2010 business strategy involves a shift in focus to acquiring more assets, organic growth and diversification and increase of our revenue streams," Mr. Schissler explains in the interview. Also included in the comprehensive interview is an update on the Company's new headquarters and laboratory in Las Vegas, an explanation on why the new laboratory is so important for investors, a discussion of the Company's debt reduction program, and a synopsis of successes in 2009.

Cord Blood America (BULLETIN BOARD: CBAI) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (BULLETIN BOARD: CBAI) , visit our website at http://www.corcell.com/. For investor information, visit http://www.cordblood-america.com/.

Forward-Looking Statements

Some statements made in this press release are forward-looking statements, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. We use words such as "anticipate,' "believe,' "expect,' "future,' "intend,' "plan,' and similar expressions to identify forward-looking statements. These statements including those related to the growth of the industry, new stem cell treatments, and the Company's performance, are only predictions and are subject to certain risks, uncertainties and assumptions. Additional risks are identified and described in the Company's public filings with the Securities and Exchange Commission. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. The Company's past performance is not necessarily indicative of its future performance. The Company does not undertake, and the Company specifically disclaims any obligation to update any forward-looking statements to reflect occurrences, developments, events, or circumstances after the date of such statement.

http://www.finanznachrichten.de/...gies-in-internet-interview-008.htm

http://www.cordblood-america.com/  

... werden in den nächsten Wochen wohl noch so einige kommen - nur dann zu anderen Kursen!  ;-)

Wenn CBAI sein Potenzial nur annähernd nutzt, geht hier ordentlich was. (meine Meinung, keine Empfehlung zu irgendwas)

Was will man denn für einen ordentlichen Start im Hot Stock-Bereich!!! mehr verlangen wie:

- in 2009 Schuldenabbau in Millionenhöhe!
- Bezug eines hochmodernen Labor!
- positive Medienberichte über CBAI
- Werbung in verschiedenen Fernsehbereichen
- ordentliche Presseabteilung
- steht erst am Anfang des Unternehmensaufbaus
- Weltweit tätig!
- ich bin investiert ;-)


u.s.w.



Natürlich würde ich nicht gleich Haus und Hof setzten, aber hier hat m. M. nach heute jede Anlage eine reelle Chance - gerade mittelfristig - auf eine Vervielfachung. Also Kleinvieh mach auch (viel?) Mist.

Doch dabei nie vergessen, wo wir hier momentan noch sind, im Highrisk-Subpennyland - vielleicht aber nicht mehr lange!?

Glück auf!  

ist es !!!!!
einfach long denken und es wird was :)  

vollkommen recht :-))))
 

lesen interview cbai 

 

ttp://www.earthtimes.org/articles/show/...-internet-interview,1011616.shtml  

scheint hier was zu gehen ;-)

good luck an alle Investierten...  

gut aus :-)))  zum WE brauch man das :-))) LG Bee
 

recherche betreiben habe, steht für mich fest, das  CORD BLOOD ein gute anlagestrategie ist. hier gibt es zum glück keine fda leichen im keller!  
@brunneta deine schreibweise ist sehr angenehm und nicht so überheblich und selbstherrlich wie bei manch anderen usern

schönes we

schilo

und kann meiner Meinung nach überhaupt nicht falsch sein...

Unser Erntedankfest wird hier noch kommen....

da bin ich mir sicher....  

Hi Schilo- Du meinst doch nicht etwa den Herr`n W aus der G Aktie  :-)

http://translate.google.de/...amp;sl=en&tl=de&history_state0=